Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

188.01
-5.0200-2.60%
Post-market: 189.000.9900+0.53%19:59 EST
Volume:3.03M
Turnover:573.88M
Market Cap:291.60B
PE:62.48
High:192.76
Open:191.80
Low:187.06
Close:193.03
52wk High:193.97
52wk Low:122.48
Shares:1.55B
Float Shares:1.54B
Volume Ratio:0.93
T/O Rate:0.20%
Dividend:3.13
Dividend Rate:1.66%
EPS(TTM):3.01
EPS(LYR):4.50
ROE:21.67%
ROA:9.06%
PB:6.35
PE(LYR):41.78

Loading ...

Earning Preview: AstraZeneca PLC Q4 revenue is expected to increase by 8.99%, and institutional views are bullish

Earnings Agent
·
Feb 03

AstraZeneca PLC Stock Falls Monday, Underperforms Market

Dow Jones
·
10 hours ago

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Yesterday

AstraZeneca's Weight-Loss Drug Strategy in Focus -- Earnings Preview

Dow Jones
·
Yesterday

Joint Vaccine Venture Between Kangtai Biological and AstraZeneca Terminated Following Market Shifts

Deep News
·
Feb 08

TrumpRx Is Here. Most People Won't Benefit. -- Barrons.com

Dow Jones
·
Feb 07

Bilateral Collaboration Accelerates as UK Prime Minister's Visit Highlights New Logic for Sino-British Cooperation

Deep News
·
Feb 06

AstraZeneca's Novel Bispecific Antibody Receives Clinical Trial Approval in China

Stock News
·
Feb 06

AstraZeneca PLC Stock Rises Thursday, Outperforms Market

Dow Jones
·
Feb 06

European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading

MT Newswires Live
·
Feb 06

NYSE Content Advisory: Pre-Market Update + AstraZeneca Climbs Nearly 1% After Historic NYSE Transfer

prnewswire
·
Feb 03

AstraZeneca Expects FDA Decision on Updated Subcutaneous Saphnelo Application in H1 2026

MT Newswires Live
·
Feb 03

AstraZeneca (AZN.US) Stock Drops Nearly 2% as FDA Rejects Self-Injectable Lupus Drug Application

Stock News
·
Feb 03

AstraZeneca Says Breast Cancer Treatment Granted US FDA Priority Review

MT Newswires Live
·
Feb 03

AstraZeneca rises 106.9%

TIPRANKS
·
Feb 03

AstraZeneca PLC Stock Rises Monday, Outperforms Market

Dow Jones
·
Feb 03

AstraZeneca’s Imfinzi perioperative regimen recommended for approval in EU

TIPRANKS
·
Feb 02

AstraZeneca (AZN.US) Lists on NYSE, Intensifying US Focus and Potentially Weakening London's Status

Stock News
·
Feb 02

AstraZeneca to Begin NYSE Trading; Says Imfinzi Recommended by EU as Gastric Cancer Treatment

MT Newswires Live
·
Feb 02

CICC Maintains "Outperform" Rating on CSPC PHARMA (01093) Following Major AstraZeneca Collaboration

Stock News
·
Feb 02